Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6′-nitrobenzofuran-2′-yl)-1,3,4-oxadiazoles
作者:Muhammad Taha、Nor Hadiani Ismail、Syahrul Imran、Abdul Wadood、Fazal Rahim、Syed Muhammad Saad、Khalid Mohammed Khan、Abdul Nasir
DOI:10.1016/j.bioorg.2016.04.006
日期:2016.6
Twenty derivatives of 5-aryl-2-(6′-nitrobenzofuran-2′-yl)-1,3,4-oxadiazoles (1–20) were synthesized and evaluated for their α-glucosidase inhibitory activities. Compounds containing hydroxyl and halogens (1–6, and 8–18) were found to be five to seventy folds more active with IC50 values in the range of 12.75 ± 0.10–162.05 ± 1.65 μM, in comparison with the standard drug, acarbose (IC50 = 856.45 ± 5
合成了20种5-芳基-2-(6'-硝基苯并呋喃-2'-基)-1,3,4-恶二唑衍生物(1 – 20),并评估了其对α-葡萄糖苷酶的抑制活性。(含羟基和卤素的化合物1 - 6,和8 - 18被认为是五到70倍带IC多种活性)50个在12.75±0.10-162.05±1.65μM的范围内的值,在与标准药物,阿卡波糖相比(IC 50 = 856.45±5.60μM)。当前的研究探索了α-葡糖苷酶抑制恶二唑和苯并呋喃化合物的混合类。这些发现可能会邀请研究人员从事高血糖治疗领域的研究。对接研究表明,大多数化合物通过氢键和芳烃-芳烃相互作用与重要氨基酸Glu 276,Asp 214和Phe 177相互作用。